OVERVIEW 

  • Discuss Burden of Disease for Stroke
  • Discuss Etiology/Pathophysiology for Acute Ischemic Stroke
  • Discuss Risk of Recurrent Stroke/Transient Ischemic Attack (TIA)
  • Discuss Platelet Physiology after an Acute Ischemic Stroke/TIA
  • Discuss Patient Care Pathway for Acute Ischemic Stroke/TIA
  • Discuss the use of BRILINTA® (ticagrelor) in Patients with Acute Ischemic Stroke/High-Risk Transient Ischemic Attack
  • Discuss BRILINTA Pivotal Trials 
  • Discuss the THALES Trial

This content is developed exclusively by or on behalf of the industry sponsor; it is not reviewed or associated with Pri-Med and Pri-Med does not endorse or sanction any third-party content.